Bioharvest Sciences Q3 2026 earnings

BHST · 2026-10-29 16:45 AMC ET · 6-K on SEC

The company announced the date for its Q3 2026 financial results, highlighting a strategic transformation towards a CDMO-focused business model.

Headline numbers

not stated in the 6-K

Revenue breakdown

not stated in the 6-K

Margins and costs

  • Gross margin not stated in the 6-K
  • Operating expenses not stated in the 6-K
  • One-offs in the quarter not stated in the 6-K
  • Effective tax rate not stated in the 6-K
  • Non-GAAP bridge not stated in the 6-K

KPIs

MetricActualPrior quarterPrior yearChange
Earnings Call DateNovember 12, 2026———

Guidance

not stated in the 6-K

What drove it

  • Revenue story not stated in the 6-K
  • EPS story not stated in the 6-K
  • One-off check not stated in the 6-K

The good

  • Strategic transformation to a CDMO-focused business model is progressing.

The bad

  • none

The ugly

  • none

Open questions

  • What are the specific financial metrics to be reported on November 12, 2026?
  • What is the timeline and scale of the CDMO business ramp-up?
Full release

Earnings: BHST — filed 2026-10-29

Bioharvest Sciences Inc. (BHST) · Form 6-K · Filed · SEC filing

BioHarvest Sciences to Report Third Quarter 2026 Financial Results on November 12, 2026

Vancouver, British Columbia and Rehovot, Israel – October 29, 2026

-- BioHarvest Sciences Inc. (“BioHarvest” or the “Company”), (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will report its third quarter 2026 financial results before the market opening on Thursday, November 12, 2026. The Company will host a conference call and webcast at 8:00 AM Eastern Time to discuss the results and provide an update on business operations.

"I invite our shareholders to join our upcoming Q3 earnings call, where I will share important developments and achievements that are shaping BioHarvest’s future as a CDMO-focused company,” commented Chief Executive Officer Zaki Rakib. “Beyond the quarterly financial results, I look forward to discussing the progress of our strategic transformation and the opportunities we see for building a scalable business with significant long-term revenue growth potential and profitability.”

Third

Quarter 202⁶

Earnings Call

The earnings call webcast will be broadcast live, and attendees are encouraged to register via the webcast link at least 10 minutes prior to the call to ensure timely participation.

The webcast recording will be available for replay on the Company’s website within the Investor Relations/Events & Presentations section.

About BioHarvest

BioHarvest Sciences Inc. (Nasdaq: BHST) (TASE: BHST) (FSE: 8MV0) is a biotechnology company pioneering its proprietary Botanical Synthesis™ technology, an advanced plant-cell-based platform designed to produce valuable plant-derived compounds without growing and harvesting the complete source plant.

The Company applies Botanical Synthesis™ across its proprietary asset portfolio and through its CDMO business to develop and manufacture high-value plant-derived compounds for customers and commercial partners. VINIA® represents BioHarvest’s first commercialized product and provides a demonstrated pathway from plant-cell development through manufacturing and commercialization. BioHarvest is applying that same platform to build a broader portfolio of proprietary and customer-sponsored assets across multiple high-value categories.

Forward-Looking Statements

Information set forth in this news release might include forward-looking statements that are based on management’s current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHST does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures. Forward-looking statements include those set forth in the Risk Factors section of the Company’s Securities and Exchange Commission (SEC)’s filings which can be found within the Investor Relations section on the Company’s website, or on the SEC’s website at http://www.sec.gov.

BioHarvest Sciences Contact:

Justin Meiklem

Head of Corporate Communications

Direct (778) 686-3855

Office (604) 622-1186

Justin@bioharvest.com

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.